The Coaching for Cognition in Alzheimer's (COCOA) trial: Study design

The Coaching for Cognition in Alzheimer's (COCOA) trial: Study design

Abstract Comprehensive treatment of Alzheimer's disease (AD) requires not only pharmacologic treatment but also management of existing medical conditions and lifestyle modifications including diet, cognitive training, and exercise. We present the design and methodology for the Coaching for Cogn...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jared C. Roach, Junko Hara, Deborah Fridman, Jennifer C. Lovejoy, Kathleen Jade, Laura Heim, Rachel Romansik, Adrienne Swietlikowski, Sheree Phillips, Molly K. Rapozo, Maria A. Shay, Dan Fischer, Cory Funk, Lauren Dill, Michael Brant‐Zawadzki, Leroy Hood, William R. Shankle
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:	Alzheimer's disease Alzheimer's disease and related disorders cognitive decline cognitive impairment cognitive training dementia
Online Access:	https://doi.org/10.1002/trc2.12318
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Accuracy of the Brief Cognitive Screening Battery for diagnosing Alzheimer's disease defined by cerebrospinal fluid biomarkers and AT(N) classification: a case-control study
by: Patrícia Regina Henrique Peles, et al.
Published: (2021-11-01)

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
by: Andrew P. Merluzzi, et al.
Published: (2019-01-01)

The bidirectional relationship between subjective visual function and domain-specific cognition in cognitively unimpaired older adults and adults with mild cognitive impairment
by: Abigail Dubois, et al.
Published: (2024-11-01)

Computerized cognitive testing to capture cognitive decline in Alzheimer's disease: Longitudinal findings from the ARMADA study
by: Roos J. Jutten, et al.
Published: (2025-01-01)

Effect of levetiracetam on cognition in patients with cognitive decline: A systematic review and meta‐analysis of randomized controlled trials
by: Claudia Faini, et al.
Published: (2025-08-01)

Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations: Proceedings from the Alzheimer's Association Research Roundtable (AARR) Fall 2021 meeting
by: Ronald C. Petersen, et al.
Published: (2025-01-01)

Study Effect of the COVID-19 Lockdown on the Transition from Mild Cognitive Impairment to Dementia
by: Jigar Sanjiv Padhiar, et al.
Published: (2025-06-01)

The economic burden of subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia: excess costs and associated clinical and risk factors
by: Eva Gläser, et al.
Published: (2025-06-01)

Effectiveness of Repetitive Transcranial Magnetic Stimulation in Mild Cognitive Impairment and Early Alzheimer’s Disease: A Systematic Review and Meta-analysis
by: Palash Kumar Malo, et al.
Published: (2025-01-01)

Focused transcranial ultrasound for treatment of neurodegenerative dementia
by: Natalie Eleanor Nicodemus, et al.
Published: (2019-01-01)

Tau Imaging: Use and Implementation in New Diagnostic and Therapeutic Paradigms for Alzheimer’s Disease
by: Alexandra Gogola, et al.
Published: (2025-02-01)

Efficacy of medications in controlling cognitive dysfunction in Alzheimer’s : a systematic review
by: Sâmia Moreira de Andrade, et al.
Published: (2025-08-01)

Cognitive Disorders Awareness and Associated Risk Factors in Xizang Autonomous Region
by: HAO Yu, et al.
Published: (2025-01-01)

Mechanisms and functions of the cerebral-cognitive reserve in patients with Alzheimer's disease: a narrative review
by: Alena P. Sidenkova, et al.
Published: (2024-10-01)

Cognitive Effect of Levetiracetam in Patients with Alzheimer’s Disease or Mild Cognitive Impairment: A Systematic Review
by: Mohamad Hosein Mohamadi, MD, et al.
Published: (2025-01-01)

INSULIN RESISTANCE AS A RISK FACTOR FOR COGNITIVE DYSFUNCTION
by: Antoniya Hachmeriyan, et al.
Published: (2025-03-01)

Drinking coffee may reduce chances of developing Alzheimer’s disease: systematic literature review and meta-analysis
by: Sheba R. David, et al.
Published: (2022-10-01)

Argentina-Alzheimer's disease neuroimaging initiative (Arg-ADNI): neuropsychological evolution profile after one-year follow up
by: Patricio Chrem Méndez, et al.

Promising neuroprotective potential of naringenin against trimethyltin-induced cognitive deficits and hippocampal neurodegeneration in rats
by: Kimia Faryadras, et al.
Published: (2025-05-01)

The longitudinal effects of global and regional brain measurements on cognitive abilities
by: Fatemeh Hosseininasabnajar, et al.
Published: (2025-07-01)

Constipation and risk of cognitive impairment and dementia in adults: a systematic review and meta-analysis
by: Qiyue Wang, et al.
Published: (2025-06-01)

Trajectory of plasma lipidome associated with the risk of late-onset Alzheimer's disease: a longitudinal cohort studyResearch in context
by: Tingting Wang, et al.
Published: (2025-08-01)

Occupational therapy combined with computerized cognitive remediation therapy for the treatment of early-onset Alzheimer's disease： a case report
by: Liu Xiaowei, et al.
Published: (2025-06-01)

Early Diagnosis of Alzheimer’s Disease in Human Participants Using EEGConformer and Attention-Based LSTM During the Short Question Task
by: Seul-Kee Kim, et al.
Published: (2025-02-01)

A systematic review and meta-analysis of the impact of transcranial direct current stimulation on cognitive function in older adults with cognitive impairments: the influence of dosage parameters
by: Thatchaya Prathum, et al.
Published: (2025-02-01)

Expanding the Applicability of Cognitive Charts to the Entire Age Span
by: Christian Gourdeau, et al.
Published: (2025-03-01)

Linking cognitive and behavioral reserve: Evidence from the CAN‐PROTECT study
by: Dylan X. Guan, et al.
Published: (2024-10-01)

Levels of chemokines and other inflammatory mediators in patients with mild cognitive impairment undergoing rehabilitation
by: I. K. Malashenkova, et al.
Published: (2023-06-01)

Unravelling Shared Pathways Linking Metabolic Syndrome, Mild Cognitive Impairment, Dementia, and Sarcopenia
by: Daniela Ceccarelli Ceccarelli, et al.
Published: (2025-02-01)

Meditation for subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials
by: Jiaxin Shi, et al.
Published: (2025-05-01)

Rethinking the residual approach: leveraging statistical learning to operationalize cognitive resilience in Alzheimer’s disease
by: Colin Birkenbihl, et al.
Published: (2025-01-01)

The Use and Understanding of Mild Cognitive Impairment in Routine Specialist Care: A Survey Among German Memory Clinics
by: Gloria S. Benson, et al.
Published: (2025-02-01)

Performances on the Timed Up and Go Test and subtasks between fallers and non-fallers in older adults with cognitive impairment
by: Juliana Hotta Ansai, et al.

Reciprocal Interactions Between Periodontal Disease and Alzheimer’s Disease: Implications for Mutual Triggering, Exacerbation, and Treatment Interventions—A Comprehensive Review of the Literature
by: Shatha Gharaibeh, et al.
Published: (2025-05-01)

Editorial: Lifestyle and environmental influences on Alzheimer's disease: exploring the roles of diet, exercise, cognitive reserve, sleep, and air quality
by: Ruogu Cheng, et al.
Published: (2025-07-01)

Olfactory Testing and Gray Matter Volume: A Combined Approach to Predict the Conversion to Alzheimer
by: Claudia Casadio, et al.
Published: (2025-03-01)

Tau seeding activity in the cerebrospinal fluid of Alzheimer disease patients predicts short-term cognitive decline
by: Ludivine Houzé, et al.
Published: (2025-07-01)

Neurological soft signs in neurodegenerative dementias: Results of the DemeNSS study
by: Federico Emanuele Pozzi, et al.
Published: (2025-06-01)

Psychometric Properties of a Neuropsychological Assessment Scale for Diagnosing Alzheimer's Disease in the Illiterate and Low-Educated Subjects in Iran
by: Ameneh Ahmadi, et al.
Published: (2025-02-01)

Alzheimer’s disease may develop from changes in the immune system, cell cycle, and protein processing following alterations in ribosome function
by: Akiko Yamakawa, et al.
Published: (2025-01-01)